Work

Abstract PS4-01-13: Comparative efficacy of antibody drug conjugates (ADCs) in male versus female breast cancer across the spectrum of HER2 expression

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps4-01-13

Authors: D. Trapani, S. Deshmukh, S. Wu, J. Xiu, N. Lin, G. Curigliano, P. Spanheimer, S. Gandhi, S. Chumsri, S. Graff, M. Lustberg, G. Sledge, S. Tolaney, J. Leone

Institutions: University of Milan, Caris Life Sciences (United States), Dana-Farber Cancer Institute, University of North Carolina at Chapel Hill, Winship Cancer Institute, Mayo Clinic in Florida, Brown University, Lifespan, Yale University

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129626269

Cites:

Cited by:

Related to: